<DOC>
	<DOCNO>NCT01601691</DOCNO>
	<brief_summary>The purpose study evaluate usefulness dilute DuraSeal product spacer prostate rectum prostate cancer low dose brachytherapy .</brief_summary>
	<brief_title>Protection Rectum From High Radiation Doses</brief_title>
	<detailed_description>Radiation therapy prostate cancer lead inappropriate radiation dose rectum wall lead rectum adverse effect long term patient . A resorbable space prostate rectum could decrease incidence side effect . In trial , men prostate cancer intention curative treatment low dose brachytherapy recruit . Diluted DuraSeal applied rectum prostate end brachytherapy seed implantation procedure . After implantation brachytherapy seed , needle place rectum prostate perineal skin transrectal ultrasound guidance . The proper position needle confirm injection 10-15 ml sterile saline solution . After , DuraSeal component dilute 1:1 sterile saline 6-10 ml dilute product inject use DuraSeal applicator . The resolution spacer follow repeat plain computer tomography ( CT ) pelvis perform day operation , day operation , 4 week operation 8 week operation . In addition , magnetic resonance image pelvis perform 8 16 week operation . The space create prostate rectum document plain CT magnetic resonance imaging . Rectum radiation dose calculate base scan . Time DuraSeal resolution evaluate scan . Possible side effect collect subject interview follow-up visit 4 , 8 12 week operation .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>prostate cancer patient plan low dose brachytherapy treatment prostate cancer willing participate study</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>brachytherapy</keyword>
	<keyword>spacer</keyword>
	<keyword>side effect</keyword>
</DOC>